SG11202012005VA - Fluticasone furoate nasal preparation composition - Google Patents
Fluticasone furoate nasal preparation compositionInfo
- Publication number
- SG11202012005VA SG11202012005VA SG11202012005VA SG11202012005VA SG11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA SG 11202012005V A SG11202012005V A SG 11202012005VA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation composition
- fluticasone furoate
- nasal preparation
- furoate nasal
- fluticasone
- Prior art date
Links
- 229960001469 fluticasone furoate Drugs 0.000 title 1
- XTULMSXFIHGYFS-VLSRWLAYSA-N fluticasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(F)[C@@]4(C)C=CC(=O)C=C4[C@@H](F)C[C@H]3[C@@H]2C[C@H]1C)C(=O)SCF)C(=O)C1=CC=CO1 XTULMSXFIHGYFS-VLSRWLAYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018110634 | 2018-06-08 | ||
| PCT/JP2019/022743 WO2019235616A1 (fr) | 2018-06-08 | 2019-06-07 | Composition de préparation nasale de furoate de fluticasone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202012005VA true SG11202012005VA (en) | 2021-01-28 |
Family
ID=68770324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202012005VA SG11202012005VA (en) | 2018-06-08 | 2019-06-07 | Fluticasone furoate nasal preparation composition |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12102645B2 (fr) |
| EP (1) | EP3804729A4 (fr) |
| JP (1) | JPWO2019235616A1 (fr) |
| KR (1) | KR102915126B1 (fr) |
| CN (1) | CN112423763A (fr) |
| AU (1) | AU2019283247B2 (fr) |
| BR (1) | BR112020023444A2 (fr) |
| CA (1) | CA3100679A1 (fr) |
| SG (1) | SG11202012005VA (fr) |
| TW (1) | TWI859143B (fr) |
| WO (1) | WO2019235616A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022006028A2 (fr) * | 2020-06-29 | 2022-01-06 | Anovent Pharmaceutical (Us), Llc | Formulation pharmaceutique contenant une combinaison d'un agoniste bêta-2 antagoniste de m3 et de corticostéroïdes inhalés |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1210357A (en) | 1966-12-09 | 1970-10-28 | Owen Hayden | Thermal insulation structures |
| EP0709099A3 (fr) | 1994-09-28 | 1996-07-24 | Senju Pharma Co | Suspension aqueuse nasale comprenant cyclodextrine |
| US7074388B2 (en) | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| SI1775305T1 (sl) | 2000-08-05 | 2015-01-30 | Glaxo Group Limited | S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo |
| JP2006069946A (ja) * | 2004-09-01 | 2006-03-16 | Aska Pharmaceutical Co Ltd | 微量定量噴霧用の水性懸濁剤 |
| US8136703B2 (en) | 2006-04-21 | 2012-03-20 | Toko Yakuhin Kogyo Kabushiki Kaisha | Fluid container and airless fluid dispensing system |
| DK2014305T3 (en) * | 2006-04-21 | 2017-10-16 | Toko Yakuhin Kogyo Kk | SPRAYABLE GEL-SHAPED SKIN / MOSPHONE ADHESIVE AND ADMINISTRATIVE SYSTEM FOR USING THE PREPARATION |
| CN101474192A (zh) * | 2009-01-20 | 2009-07-08 | 崔晓廷 | 糠酸氟替卡松药物制剂及制备方法 |
| WO2012094283A2 (fr) | 2011-01-04 | 2012-07-12 | Ista Pharmaceuticals, Inc. | Compositions de bépostatine |
| RU2652352C2 (ru) | 2012-12-17 | 2018-04-25 | Глаксо Груп Лимитед | Комбинация левокабастина и флутиказона фуроата для лечения воспалительных и/или аллергических состояний |
-
2019
- 2019-06-07 CA CA3100679A patent/CA3100679A1/fr active Pending
- 2019-06-07 WO PCT/JP2019/022743 patent/WO2019235616A1/fr not_active Ceased
- 2019-06-07 US US15/734,898 patent/US12102645B2/en active Active
- 2019-06-07 SG SG11202012005VA patent/SG11202012005VA/en unknown
- 2019-06-07 JP JP2020523205A patent/JPWO2019235616A1/ja not_active Withdrawn
- 2019-06-07 EP EP19814700.1A patent/EP3804729A4/fr not_active Withdrawn
- 2019-06-07 BR BR112020023444-3A patent/BR112020023444A2/pt not_active IP Right Cessation
- 2019-06-07 CN CN201980036990.5A patent/CN112423763A/zh active Pending
- 2019-06-07 KR KR1020217000147A patent/KR102915126B1/ko active Active
- 2019-06-07 AU AU2019283247A patent/AU2019283247B2/en active Active
- 2019-06-10 TW TW108119910A patent/TWI859143B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019283247B2 (en) | 2025-03-27 |
| JPWO2019235616A1 (ja) | 2021-06-17 |
| KR102915126B1 (ko) | 2026-01-20 |
| CA3100679A1 (fr) | 2019-12-12 |
| KR20210020068A (ko) | 2021-02-23 |
| BR112020023444A2 (pt) | 2021-02-23 |
| TWI859143B (zh) | 2024-10-21 |
| US20210236515A1 (en) | 2021-08-05 |
| AU2019283247A1 (en) | 2020-12-24 |
| TW202015700A (zh) | 2020-05-01 |
| EP3804729A1 (fr) | 2021-04-14 |
| WO2019235616A1 (fr) | 2019-12-12 |
| EP3804729A4 (fr) | 2022-03-09 |
| US12102645B2 (en) | 2024-10-01 |
| CN112423763A (zh) | 2021-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201906613B (en) | Pharmaceutical compositions for combination therapy | |
| IL261924A (en) | Steroid hormone pharmaceutical composition | |
| ZA201806414B (en) | Steroid hormone pharmaceutical composition | |
| ZA201905510B (en) | Pharmaceutical compositions for combination therapy | |
| GB201911517D0 (en) | Pharmaceutical composition | |
| GB201807053D0 (en) | Pharmaceutical composition | |
| GB201804548D0 (en) | Pharmaceutical compositions | |
| ZA202006541B (en) | Pharmaceutical composition comprising brexpiprazole | |
| HUE064916T2 (hu) | Gyógyászati készítmény | |
| PL3823655T3 (pl) | Kompozycje do leczenia wulwodynii | |
| PL3606505T3 (pl) | Kompozycja do podawania donosowego | |
| GB201808571D0 (en) | Pharmaceutical compositions | |
| GB201808567D0 (en) | Pharmaceutical compositions | |
| IL285728A (en) | Pharmaceutical composition | |
| EP3593801A4 (fr) | Composition d'émulsion acide contenant un agent anesthésique local | |
| SG11202012005VA (en) | Fluticasone furoate nasal preparation composition | |
| PL3949952T3 (pl) | Kompozycja farmaceutyczna | |
| SG11202103374TA (en) | Pharmaceutical composition | |
| PT3650024T (pt) | Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência | |
| ZA202103782B (en) | Teriflunomide topical pharmaceutical compositions | |
| SG11202103851PA (en) | Dry pharmaceutical composition for inhalation | |
| GB201912686D0 (en) | Pharmaceutical composition | |
| PT3893845T (pt) | Composição compreendendo dutasterida | |
| GB201820689D0 (en) | Pharmaceutical composition | |
| GB201908003D0 (en) | Pharmaceutical composition |